Association of chemotherapy dose intensity and age with outcomes in patients with Ewing's family sarcoma.
Danielle KlingbergSusie BaeDeborah Di-Xin ZhouHao-Wen SimRuilin CaiAntoinette AnazodoPeter S GrimisonCraig LewisYeh Chen LeePublished in: Asia-Pacific journal of clinical oncology (2023)
Survival outcomes in EFS were associated with chemotherapy RDI. Older adults more commonly required dose reduction or early cessation of treatment due to toxicity. VDC/IE chemotherapy should be carefully tailored in adults > 40 years.